Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v3-EN
Language French English
Date Updated 2019-08-19 2019-06-07
Drug Identification Number 02293838 02293838
Brand name APO-LANSOPRAZOLE APO-LANSOPRAZOLE
Common or Proper name LANSOPRAZOLE LANSOPRAZOLE
Company Name APOTEX INC APOTEX INC
Ingredients LANSOPRAZOLE LANSOPRAZOLE
Strength(s) 30MG 30MG
Dosage form(s) CAPSULE (DELAYED RELEASE) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-05-14 2019-05-14
Estimated end date 2019-08-16 2019-08-16
Actual end date 2019-08-16
Shortage status Resolved Actual shortage
Company comments
Health Canada comments